Form 8-K - Current report:
SEC Accession No. 0001193125-25-004939
Filing Date
2025-01-13
Accepted
2025-01-13 06:50:34
Documents
15
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d925380d8k.htm   iXBRL 8-K 27875
2 EX-99.1 d925380dex991.htm EX-99.1 21571
6 GRAPHIC g925380g0112055637388.jpg GRAPHIC 3386
  Complete submission text file 0001193125-25-004939.txt   187267

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20250113.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20250113_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20250113_pre.xml EX-101.PRE 11725
17 EXTRACTED XBRL INSTANCE DOCUMENT d925380d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 25524717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)